0       0


MN2-11: Ask the FDA and CMS


Oct 21, 2019 10:30am ‐ Oct 21, 2019 12:00pm

Description

Spanish Captions Available

Pregúntele a la Agencia Federal de Fármacos (FDA) y a los Centros de Servicios de Medicare/Medicaid

This annual event provides an opportunity for FDA and CMS/CLIA representatives to respond to member questions and present the agency's current thinking on policies, regulations, guidance documents and inspection programs that are relevant to the oversight of blood and HCT/P programs. Questions for the session are submitted in advance to regulatory@aabb.org. Identify the regulation or recommendation of interest, the specific issue or concern, and any background information, suggestions or proposed solutions to best illustrate your perspective.

At the completion of this session, participants should be able to:

  • Evaluate existing practices to establish alignment with current regulatory requirements and recommendations
  • Apply FDA's recommendations in recently issued guidance to industry
  • Describe FDA's approach for blood and HCT/P policies, regulations and inspection programs

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content